Patients and RWE: Is this the year?
There is reason to hope that the long-awaited breakthroughs flowing from patient-generated data are about to happen
Close log in window
There is reason to hope that the long-awaited breakthroughs flowing from patient-generated data are about to happen
Collaboration makes sense on many fronts on our journey to sustainably improve the lives of patients, says Merck’s Chris Round
Artificial intelligence and digital are already transforming medical service delivery in China and it’s heading west rapidly
Without the right approach to risk and culture, pharma may miss the big opportunities, says Bayer’s Sebastian Guth
